CTRI Number |
CTRI/2023/10/058853 [Registered on: 19/10/2023] Trial Registered Prospectively |
Last Modified On: |
18/10/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Effect of addition of clonidine or fentanyl to spinal 0.75% hyperbaric(heavy) ropivacaine in lower limb surgeries.
|
Scientific Title of Study
|
Effect of addition of clonidine or fentanyl to intrathecal 0.75% hyperbaric ropivacaine in lower limb surgeries:- A randomized controlled clinical study.
|
Trial Acronym |
nil |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Deepak Kumar |
Designation |
Post Graduate Resident |
Affiliation |
Maharaja Agrasen Medical College Agroha, Hisar, Haryana |
Address |
Department of Anaesthesia
Maharaja Agrasen Medical College
Agroha, Hisar, Haryana
Hisar HARYANA 125047 India |
Phone |
9416304998 |
Fax |
|
Email |
deepakkamboj1984@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sheetal |
Designation |
Professor |
Affiliation |
Maharaja Agrasen Medical College Agroha, Hisar, Haryana |
Address |
Department of Anaesthesia
Maharaja Agrasen Medical College
Agroha, Hisar, Haryana
Hisar HARYANA 125047 India |
Phone |
8950426301 |
Fax |
|
Email |
sheetalbhatia1234@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Rishabh |
Designation |
Assistant Professor |
Affiliation |
Maharaja Agrasen Medical College Agroha, Hisar, Haryana |
Address |
Department of Anaesthesia
Maharaja Agrasen Medical College
Agroha, Hisar, Haryana
Hisar HARYANA 125047 India |
Phone |
8130449525 |
Fax |
|
Email |
agarwalrishabh66@gmail.com |
|
Source of Monetary or Material Support
|
Maharaja agrasen medical college agroha, hisar, Haryana |
|
Primary Sponsor
|
Name |
Dr Deepak Kumar |
Address |
Maharaja Agrasen Medical College Agroha, Hisar, Haryana |
Type of Sponsor |
Other [self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Deepak Kumar |
Maharaja Agrasen Medical College Agroha, Hisar, Haryana |
Department of Anaesthesia, Maharaja Agrasen Medical College Agroha, Hisar, Haryana
pin- 125047 Hisar HARYANA |
9416304998
deepakkamboj1984@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee for Human Reserch, Maharaja Agrasen Medical College, Agroha Hisar Haryana |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Inj ropivacaine(0.75% hyperbaric) + Inj clonidine. |
2.5ml of 0.75% hyperbaric ropivacaine + 15 mcg clonidine (0.1 ml) ) + 0.4 ml normal saline-total volume 3.0 ml for intrathecal block. |
Intervention |
Inj ropivacaine(0.75% hyperbaric) + Inj fentanyl. |
2.5ml of 0.75% hyperbaric ropivacaine + 25 mcg fentanyl (0.5 ml) for intrathecal block. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1. Adult patients of either sex, aged between 18-60 years age.
2. American Society of Anaesthesiologists (ASA) I and II status
|
|
ExclusionCriteria |
Details |
1. Patient’s refusal for the procedure
2. Known drug allergy
3. Pregnant patient
4. Body mass index ≥30 kg/m2
5. Spine/ Neurological or coagulation disorders.
6. Patients with known cardio respiratory diseases.
7. Duration of surgery less than 60 min
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
1.To determine the duration of sensory & motor block.
2.To determine time of 1st rescue analgesia.
|
1.Duration of sensory block is measured from Time of onset of sensory block to regression at S1.
Duration of motor block is measured from Time of onset of motor block to complete recovery i.e. Bromage 0.
2.Time of administration of first rescue analgesia is measured from Time of onset of sensory block to demand of first analgesia and/ or VAS 3 in PACU/Ward. |
|
Secondary Outcome
|
Outcome |
TimePoints |
1.To determine Onset of sensory & motor block.
2.To determine Haemodynamic changes.
3.To determine Side effects if any. |
1.Onset of sensory block is measured from Time of intrathecal injection to sensory loss at S1. &
Onset of motor block is measured from Time of intrathecal injection till Bromage scale 3.
2.Incidence of hemodynamic changes such as hypotension, bradycardia during intra-operative period
3.side effects. |
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
28/10/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [deepakkamboj1984@gmail.com].
- For how long will this data be available start date provided 01-12-2024 and end date provided 01-12-2027?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
Brief Summary
|
To compare the effects of Fentanyl and Clonidine as adjuvant to 0.75% hyperbaric Ropivacaine on duration of intrathecal block . Objective:-Primary 1. To determine the duration of sensory and motor block. 2. To determine time of 1st rescue analgesia. Secondary 1. To determine Onset of sensory and motor block. 2. To determine Haemodynamic changes. 3. To determine Side effects if any. Group allocation-The patients undergoing elective lower limb
surgeries will be divided into one of
the two groups of 40 each
Group-RF (40)-2.5ml of 0.75% hyperbaric ropivacaine + 25 mcg
fentanyl (0.5 ml) =total volume 3.0 ml Group-RC (40)-2.5ml of 0.75% hyperbaric
ropivacaine + 15 mcg clonidine (0.1 ml)+ 0.4 ml normal saline= total volume 3.0
ml.
Study drug will be prepared by first anaesthesiologist in a
sterile unlabelled syringe according to group allocation. Under all aseptic
precautions, lumbar puncture will be performed in L2–L3/L3–L4 inter vertebral
space in sitting position using a 25G Quincke’s spinal needle and study drug
will be injected by the second anaesthesiologist who will remain blinded to
composition of drug.. Time of intrathecal injection will be noted. Continuous
Monitoring of the BP, HR, SpO2, and ECG will be done.
Sensory block will be assessed by the loss of sensation to
pinprick using a 25G blunt needle along the mid-axillary line bilaterally every
2 min till two consecutive readings remain the same i.e., highest cephalad
spread of sensory block has occurred. The time of sensory block at T12 will be
noted as onset of sensory block and the surgeon will be allowed to start the
surgery. Regression of sensory block till S1 will be noted as duration of
sensory block. Time of 1st rescue analgesia will be determined from the time of
onset of sensory block till patient demands the first rescue analgesic and/ or
VAS > 3 in post-anaesthesia care unit. Visual Analogue Scale (VAS) is used,
wherein 0=no pain, and 10=severe pain every 15 minutes in the post anaestheia
care unit. Rescue analgesia will be given with Inj. Diclofenac 75 mg iv
infision.
Motor block will be assessed according to Bromage scale
i.e., Bromage 0: Patients able to move hip, knee, and ankle, Bromage 1:
Patients unable to move hip but able to move the knee and ankle, Bromage 2:
Patient unable to move hip and knee but able to move the ankle, Bromage 3:
Patient unable to move hip, knee, and ankle. Motor block will be accessed every
2 minute interval. Onset of maximum motor block is defined as the time from
intrathecal injection of the drug to attain Bromage scale 3. Duration of motor
block is defined as the time taken from the onset of motor block to complete
recovery of motor block i.e. Bromage score of 0. Complications such as
hypotension, bradycardia, nausea, vomiting, shivering, pruritus if any, in the
intra-operative as well as postoperative period will be noted in a prepared
Proforma and will be managed accordingly. Following parameters will be observed: 1. Demographic parameters: Age, gender, weight, height, BMI and duration of surgery. 2. Study parameters 1. Onset of sensory block: Time from intrathecal injection to sensory loss at T12. 2. Duration of sensory block: Time from onset of sensory block to regression at S1. 3. Time of administration of first rescue analgesia: Time from onset of sensory block to demand of first analgesia and/ or VAS > 3 in PACU/Ward. 4. Onset of motor block: Time from intrathecal injection till Bromage scale 3. 5. Duration of motor block: Time from onset of motor block to complete recovery i.e. Bromage 0. 6. Incidence of hemodynamic changes such as hypotension, bradycardia and other side effects. |